Browsing: Mortality
Longevity and Mortality Investor’s coverage of mortality news, data and trends including clinical mortality, population mortality and behavioural mortality
Those advising insurance companies and pension schemes on mortality are paying very close attention to developments with anti-obesity medicines.
The outlook for metastatic melanoma continues to improve, driven by advancements in therapeutic strategies and ongoing research.
New research suggests that the chances then that the next 100 years or so brings about a similar jump?
It could take decades for the new legislation to have any discernible impact on mortality.
While ageing is fundamentally a physiological phenomenon, numerous factors significantly influence the rate at which this process occurs. Certain factors can accelerate the ageing process, while some have the potential to decelerate it, influencing the rate of physiological decline.
Dr. Rahul Nawander, Medical Director at Fasano Underwriting, offers his views on what is impacting LEs generally from a medical perspective.
New technological advances to meet key healthcare needs are a crucial element driving the performance profile of the healthcare sector.
New analysis from consulting firm LCP suggests the value of the €20-30bn of Dutch pension fund liabilities expected to be bought out by insurers by 2027 could differ by at least €500m depending on the model used.
New analysis by consulting firm Lane, Clark & Peacock finds that life expectancy assumptions are significantly higher than plausible alternative projections.
A new report from Swiss Re suggests that excess mortality may continue to remain higher then pre-pandemic levels unless action is taken.